Trial intelligence / Profile preview

DIPAVO: Droperidol in the Prevention of Postoperative Nausea and Vomiting in Thyroid Surgery

NCT00445055Phase 4Terminated

Sponsor
Centre Hospitalier Universitaire de Bordeaux
Start
Apr 2007
Primary completion
Apr 2009
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of droperidol in postoperative nausea and vomiting (PONV), sponsored by Centre Hospitalier Universitaire de Bordeaux. Started Apr 2007; status: terminated.

02

Drugs

droperidol
03

Conditions

postoperative nausea and vomiting (PONV)

Beyond the preview

Go deeper on NCT00445055.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00445055.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call